February 13, 2015 article Open access Compstatin: a C3‐targeted complement inhibitor reaching its prime for bedside intervention European Journal of Clinical Investigation DOI: 10.1111/eci.12419 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 3 stored of 211 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity 2024 Frontiers in Immunology article Immunology and Microbiology Complement system in diseases Open access cited by 2 patents 16 citations Discovering C3 targeting therapies for paroxysmal nocturnal hemoglobinuria: Achievements and pitfalls 2022 Seminars in Immunology article Immunology and Microbiology Complement system in diseases 18 citations Halting targeted and collateral damage to red blood cells by the complement system 2021 Seminars in Immunopathology article Immunology and Microbiology Complement system in diseases Open access 20 citations 3 results References 0